AKESO DOSES FIRST PATIENT IN PHASE II STUDY OF NOVEL TROP2/NECTIN-4 BISPECIFIC ADC (AK146D1) IN COMBINATION WITH IVONESCIMAB FOR ADVANCED NSCLC

Reuters · 3d ago

Please log in to view news